ReGen Biologics (ReGen Biologics) FCF Margin % : -894.38% (As of Jun. 2009)

View and export this data going back to 1996. Start your Free Trial

What is ReGen Biologics FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. ReGen Biologics's Free Cash Flow for the three months ended in Jun. 2009 was $-3.66 Mil. ReGen Biologics's Revenue for the three months ended in Jun. 2009 was $0.41 Mil. Therefore, ReGen Biologics's FCF Margin % for the quarter that ended in Jun. 2009 was -894.38%.

As of today, ReGen Biologics's current FCF Yield % is 0.00%.

The historical rank and industry rank for ReGen Biologics's FCF Margin % or its related term are showing as below:

RGBOQ' s FCF Margin % Range Over the Past 10 Years
Min: -648.57 Med: 0 Max: 0
Current: -648.57

RGBOQ's FCF Margin % is not ranked
in the Medical Devices & Instruments industry.
Industry Median: -7.07 vs RGBOQ: -648.57

ReGen Biologics FCF Margin % Historical Data

The historical data trend for ReGen Biologics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ReGen Biologics FCF Margin % Chart

ReGen Biologics Annual Data

Trend

Dec99

Dec00

Dec01

Dec02

Dec03

Dec04

Dec05

Dec06

Dec07

Dec08

FCF Margin %

Get a 7-Day Free Trial

-1,216.47

-1,727.72

-2,119.62

-946.15

-495.20

ReGen Biologics Quarterly Data
	Sep04	Dec04	Mar05	Jun05	Sep05	Dec05	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09
FCF Margin %	Get a 7-Day Free Trial															-806.78	-417.89	-400.00	-952.53	-894.38

Competitive Comparison of ReGen Biologics's FCF Margin %

For the Medical Instruments & Supplies subindustry, ReGen Biologics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ReGen Biologics's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ReGen Biologics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where ReGen Biologics's FCF Margin % falls into.

ReGen Biologics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

ReGen Biologics's FCF Margin for the fiscal year that ended in Dec. 2008 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2008 )	/	Revenue (A: Dec. 2008 )
	=	-6.804	/	1.374
	=	-495.20 %

ReGen Biologics's FCF Margin for the quarter that ended in Jun. 2009 is calculated as

FCF Margin	=	Free Cash Flow (Q: Jun. 2009 )	/	Revenue (Q: Jun. 2009 )
	=	-3.658	/	0.409
	=	-894.38 %

ReGen Biologics FCF Margin % Related Terms

Thank you for viewing the detailed overview of ReGen Biologics's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

ReGen Biologics (ReGen Biologics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ReGen Biologics Inc (OTCPK:RGBOQ) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

411 Hackensack Avenue, Hackensack, NJ, USA, 07601

Website

http://www.regenbio.com

ReGen Biologics Inc is an orthopedic products company. It develops, manufactures and markets innovative tissue growth and repair products for U.S. and global markets.

Executives

Gerald Jr Bisbee	director, officer: CHAIRMAN, PRESIDENT & CEO	1290 BAY DALE DRIVE, PMB 351, ARNOLD MD 21012
Robert W Pangia	10 percent owner	3965 FREEDOM CIRCLE, SANTA CLARA CA 95054
Abhi Acharya	director	13733 LEXINGTON COURT, SARATOGA CA 95070
Richard Fritschi	director

ReGen Biologics (ReGen Biologics) Headlines

No Headlines